CA3031247A1 - Methods of and systems for measuring analytes using batch calibratable test strips - Google Patents
Methods of and systems for measuring analytes using batch calibratable test strips Download PDFInfo
- Publication number
- CA3031247A1 CA3031247A1 CA3031247A CA3031247A CA3031247A1 CA 3031247 A1 CA3031247 A1 CA 3031247A1 CA 3031247 A CA3031247 A CA 3031247A CA 3031247 A CA3031247 A CA 3031247A CA 3031247 A1 CA3031247 A1 CA 3031247A1
- Authority
- CA
- Canada
- Prior art keywords
- analyte
- sensing chemistry
- test strip
- test strips
- electrode pair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 282
- 238000000034 method Methods 0.000 title claims abstract description 53
- 239000000758 substrate Substances 0.000 claims abstract description 69
- 239000012530 fluid Substances 0.000 claims abstract description 56
- 239000012491 analyte Substances 0.000 claims description 194
- 239000007789 gas Substances 0.000 claims description 172
- 238000006243 chemical reaction Methods 0.000 claims description 106
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 82
- 238000005259 measurement Methods 0.000 claims description 62
- 239000000126 substance Substances 0.000 claims description 39
- 238000004891 communication Methods 0.000 claims description 35
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims description 34
- 238000004519 manufacturing process Methods 0.000 claims description 31
- 238000005192 partition Methods 0.000 claims description 28
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 claims description 26
- 239000000853 adhesive Substances 0.000 claims description 16
- 230000001070 adhesive effect Effects 0.000 claims description 16
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000002086 nanomaterial Substances 0.000 claims description 13
- 239000012286 potassium permanganate Substances 0.000 claims description 13
- 229920000557 Nafion® Polymers 0.000 claims description 12
- -1 heterocyclic macrocycles Chemical class 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 230000003287 optical effect Effects 0.000 claims description 12
- 230000037361 pathway Effects 0.000 claims description 10
- 239000000975 dye Substances 0.000 claims description 9
- 229910044991 metal oxide Inorganic materials 0.000 claims description 9
- 150000004706 metal oxides Chemical class 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000002274 desiccant Substances 0.000 claims description 8
- 239000007800 oxidant agent Substances 0.000 claims description 8
- 229910052723 transition metal Inorganic materials 0.000 claims description 7
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 6
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims description 6
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims description 6
- 150000003624 transition metals Chemical class 0.000 claims description 6
- JYLNVJYYQQXNEK-UHFFFAOYSA-N 3-amino-2-(4-chlorophenyl)-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(CN)C1=CC=C(Cl)C=C1 JYLNVJYYQQXNEK-UHFFFAOYSA-N 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- 238000010668 complexation reaction Methods 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- 239000010410 layer Substances 0.000 description 209
- 239000000463 material Substances 0.000 description 34
- 239000000090 biomarker Substances 0.000 description 23
- 238000002560 therapeutic procedure Methods 0.000 description 19
- 230000008859 change Effects 0.000 description 18
- 239000010408 film Substances 0.000 description 16
- 238000000151 deposition Methods 0.000 description 15
- 230000004044 response Effects 0.000 description 15
- 239000002585 base Substances 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 230000008021 deposition Effects 0.000 description 13
- 230000002452 interceptive effect Effects 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 11
- 238000011088 calibration curve Methods 0.000 description 10
- 238000001514 detection method Methods 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 8
- 239000003570 air Substances 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000007613 environmental effect Effects 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 239000012080 ambient air Substances 0.000 description 7
- 208000006673 asthma Diseases 0.000 description 7
- 238000013375 chromatographic separation Methods 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- 230000035945 sensitivity Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 230000002427 irreversible effect Effects 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 150000003431 steroids Chemical class 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 239000011241 protective layer Substances 0.000 description 5
- 239000011540 sensing material Substances 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- 208000014085 Chronic respiratory disease Diseases 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 239000013626 chemical specie Substances 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 238000004590 computer program Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 239000002657 fibrous material Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003246 corticosteroid Substances 0.000 description 3
- 210000003979 eosinophil Anatomy 0.000 description 3
- 230000005713 exacerbation Effects 0.000 description 3
- 239000011152 fibreglass Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000003862 health status Effects 0.000 description 3
- 150000002431 hydrogen Chemical class 0.000 description 3
- 238000003698 laser cutting Methods 0.000 description 3
- 230000000873 masking effect Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 125000006850 spacer group Chemical group 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102100037765 Periostin Human genes 0.000 description 2
- 101710199268 Periostin Proteins 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 230000002327 eosinophilic effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229910021389 graphene Inorganic materials 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940125369 inhaled corticosteroids Drugs 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 229940127212 long-acting beta 2 agonist Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004199 lung function Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000013618 particulate matter Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- GDDNTTHUKVNJRA-UHFFFAOYSA-N 3-bromo-3,3-difluoroprop-1-ene Chemical compound FC(F)(Br)C=C GDDNTTHUKVNJRA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical class [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 238000013313 FeNO test Methods 0.000 description 1
- 206010061958 Food Intolerance Diseases 0.000 description 1
- 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 1
- 101000845170 Homo sapiens Thymic stromal lymphopoietin Proteins 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 108090000176 Interleukin-13 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 229940110339 Long-acting muscarinic antagonist Drugs 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- 229910002089 NOx Inorganic materials 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 102100031294 Thymic stromal lymphopoietin Human genes 0.000 description 1
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 1
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 150000008377 fluorones Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical class Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical compound [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- OTZRAYGBFWZKMX-JUDRUQEKSA-N leukotriene E4 Chemical compound CCCCCC=CCC=C\C=C\C=C\[C@@H](SC[C@H](N)C(O)=O)[C@@H](O)CCCC(O)=O OTZRAYGBFWZKMX-JUDRUQEKSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 229960004995 magnesium peroxide Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 239000003149 muscarinic antagonist Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-N peroxydisulfuric acid Chemical compound OS(=O)(=O)OOS(O)(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-N 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 238000010248 power generation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 229940127558 rescue medication Drugs 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000025508 response to water Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B13/00—Instruments for depressing the tongue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/552—Glass or silica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B2010/0083—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements for taking gas samples
- A61B2010/0087—Breath samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N2001/2893—Preparing calibration standards
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Sampling And Sample Adjustment (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662363971P | 2016-07-19 | 2016-07-19 | |
| US62/363,971 | 2016-07-19 | ||
| PCT/US2017/042830 WO2018017699A1 (en) | 2016-07-19 | 2017-07-19 | Methods of and systems for measuring analytes using batch calibratable test strips |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3031247A1 true CA3031247A1 (en) | 2018-01-25 |
Family
ID=60992826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3031247A Pending CA3031247A1 (en) | 2016-07-19 | 2017-07-19 | Methods of and systems for measuring analytes using batch calibratable test strips |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11255840B2 (enExample) |
| EP (2) | EP4464772A3 (enExample) |
| JP (3) | JP7086927B2 (enExample) |
| CN (2) | CN114859028A (enExample) |
| AU (1) | AU2017300528C1 (enExample) |
| CA (1) | CA3031247A1 (enExample) |
| ES (1) | ES2988367T3 (enExample) |
| WO (1) | WO2018017699A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015191558A1 (en) | 2014-06-09 | 2015-12-17 | Biometry Inc. | Low cost test strip and method to measure analyte |
| US11175268B2 (en) | 2014-06-09 | 2021-11-16 | Biometry Inc. | Mini point of care gas chromatographic test strip and method to measure analytes |
| US11172876B2 (en) * | 2018-03-13 | 2021-11-16 | Charles Gilmartin | Acoustic sensor platform method and apparatus for pain mitigation, apnea detection, aspiration detection and patient communication in anesthesia patients |
| TW202019818A (zh) | 2018-08-14 | 2020-06-01 | 加拿大國家研究委員會 | 用於ｓｗｃｎｔ電子之靛藍系聚合物 |
| GB201818584D0 (en) * | 2018-11-14 | 2018-12-26 | Exhalation Tech Limited | A device to measure breath humidity |
| US12196727B2 (en) | 2019-01-11 | 2025-01-14 | Eth Zurich | Device and method for detecting an analyte |
| WO2020154740A1 (en) * | 2019-01-25 | 2020-07-30 | Biometry Inc. | System and method for conditioning gas for analysis |
| EP3962358A1 (en) * | 2019-04-29 | 2022-03-09 | Regents of the University of Minnesota | Systems and methods for assessing and treating hemorrhage and other conditions |
| KR102795331B1 (ko) | 2019-08-20 | 2025-04-11 | 삼성전자주식회사 | 가스 농도 측정 장치 및 방법 |
| CN110487872B (zh) * | 2019-09-09 | 2021-05-07 | 北京大学 | 一种基于压舌板的电化学生物传感器 |
| US20210393163A1 (en) * | 2020-06-09 | 2021-12-23 | Graham Biosciences Llc | Device and methods for collecting and processing analytes in air/breath |
| WO2022094576A1 (en) * | 2020-10-29 | 2022-05-05 | Telophase Corporation | Rapid test breathalyzer and methods of use thereof |
| EP4236788B1 (en) | 2020-10-29 | 2025-07-23 | Telophase Corporation | Rapid test breathalyzer |
| US20220134030A1 (en) * | 2020-11-02 | 2022-05-05 | Covidien Lp | Pathogen sensing adaptors for use in breathing circuits |
| CN114002423A (zh) * | 2021-12-31 | 2022-02-01 | 深圳市帝迈生物技术有限公司 | 一种样本分析仪及其检测方法 |
| CN114895015A (zh) * | 2022-03-30 | 2022-08-12 | 新绎健康科技有限公司 | 口气成分多指标检测的自动分配装置及方法 |
| JP2023153545A (ja) * | 2022-04-05 | 2023-10-18 | 新東工業株式会社 | ガス測定器 |
| FR3148723A1 (fr) * | 2023-05-16 | 2024-11-22 | Inosystems | Appareil de délivrance de NO à capteurs MOS à longue durée de vie |
| WO2025184271A1 (en) * | 2024-03-01 | 2025-09-04 | Consumer Safety Technology, Llc | Thermal desorption system for substance detection |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4802487A (en) | 1987-03-26 | 1989-02-07 | Washington Research Foundation | Endoscopically deliverable ultrasound imaging system |
| DE3811713A1 (de) | 1988-04-08 | 1989-10-19 | Bosch Gmbh Robert | Planare polarographische sonde zur bestimmung des (lambda)-wertes von gasgemischen |
| GB8927567D0 (en) | 1989-12-06 | 1990-02-07 | Gen Electric Co Plc | Detection of chemicals |
| JP3040867B2 (ja) | 1991-12-27 | 2000-05-15 | リコーエレメックス株式会社 | 多用途センサ |
| JP2834962B2 (ja) | 1993-04-01 | 1998-12-14 | 三菱電機株式会社 | ガスセンサ |
| US5698083A (en) | 1995-08-18 | 1997-12-16 | Regents Of The University Of California | Chemiresistor urea sensor |
| DE19612680C2 (de) * | 1996-03-29 | 2000-02-03 | Inst Chemo Biosensorik | Kationselektiver Sensor |
| US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
| US6612306B1 (en) | 1999-10-13 | 2003-09-02 | Healthetech, Inc. | Respiratory nitric oxide meter |
| JP2002357589A (ja) | 2001-03-30 | 2002-12-13 | Ngk Spark Plug Co Ltd | ガスセンサ素子及びガスセンサ |
| DE10121262A1 (de) | 2001-04-30 | 2002-11-14 | Siemens Ag | Vorrichtung zur quantitativen Messung von Stickoxiden in der Ausatemluft und Verwendung |
| US6638416B2 (en) | 2001-09-24 | 2003-10-28 | Delphi Technologies, Inc. | Hydrogen sensing process |
| US7956525B2 (en) | 2003-05-16 | 2011-06-07 | Nanomix, Inc. | Flexible nanostructure electronic devices |
| US7179421B1 (en) | 2002-01-24 | 2007-02-20 | Sandia Corporation | Multi-pin chemiresistors for microchemical sensors |
| US7189360B1 (en) | 2002-01-24 | 2007-03-13 | Sandia Corporation | Circular chemiresistors for microchemical sensors |
| US6905655B2 (en) | 2002-03-15 | 2005-06-14 | Nanomix, Inc. | Modification of selectivity for sensing for nanostructure device arrays |
| US20070048180A1 (en) | 2002-09-05 | 2007-03-01 | Gabriel Jean-Christophe P | Nanoelectronic breath analyzer and asthma monitor |
| US7948041B2 (en) | 2005-05-19 | 2011-05-24 | Nanomix, Inc. | Sensor having a thin-film inhibition layer |
| US9237865B2 (en) | 2002-10-18 | 2016-01-19 | Medtronic Minimed, Inc. | Analyte sensors and methods for making and using them |
| WO2005069737A2 (en) * | 2004-01-27 | 2005-08-04 | Ramot At Tel Aviv University Ltd. | Method and system for detecting analytes |
| WO2005082934A2 (en) | 2004-02-20 | 2005-09-09 | Five Prime Therapeutics, Inc. | Novel apo2l and il-24 polypeptides, polynucleotides, and methods of their use |
| US20070264277A1 (en) | 2004-07-22 | 2007-11-15 | Dirk Behrens | Compositions and Methods of Use for Mgd-Csf in Disease Treatment |
| US20080214917A1 (en) * | 2004-12-30 | 2008-09-04 | Dirk Boecker | Method and apparatus for analyte measurement test time |
| MX2008000574A (es) | 2005-07-11 | 2008-03-14 | Sanofi Aventis | Nuevos derivados de 2,4-dianilinopirimidinas, la preparacion de los mismos, su uso como medicamentos, composiciones farmaceuticas y, en particular, como inhibidores ikk. |
| WO2008039165A2 (en) | 2005-07-20 | 2008-04-03 | Nanomix, Inc. | Carbon dioxide nanosensor, and respiratory co2 monitors |
| ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| US20070114130A1 (en) | 2005-11-18 | 2007-05-24 | Lankheet Earl W | Gas sensors and methods of manufacture |
| EP1790977A1 (en) | 2005-11-23 | 2007-05-30 | SONY DEUTSCHLAND GmbH | Nanoparticle/nanofiber based chemical sensor, arrays of such sensors, uses and method of fabrication thereof, and method of detecting an analyte |
| WO2007064912A2 (en) | 2005-12-02 | 2007-06-07 | Elan Pharma International Limited | Mometasone compositions and methods of making and using the same |
| EP2029013A4 (en) | 2006-05-18 | 2011-09-28 | Nanomix Inc | NANOELECTRONIC BREAST ANALYZER AND ASTHMA MONITORING SYSTEM |
| GB0611114D0 (en) | 2006-06-06 | 2006-07-19 | Perkinelmer Ltd | Analysis technique |
| KR101440648B1 (ko) | 2006-10-12 | 2014-09-22 | 넥스테크 머티리얼스, 엘티디. | 수소 민감성 복합 재료, 수소 및 기타 기체 검출용 튜브형 센서 |
| KR100859343B1 (ko) | 2006-10-30 | 2008-09-25 | 염충균 | 기체투과 막분석장치 및 방법 |
| US20100089772A1 (en) | 2006-11-10 | 2010-04-15 | Deshusses Marc A | Nanomaterial-based gas sensors |
| DE102007049715A1 (de) | 2006-12-29 | 2008-07-03 | Robert Bosch Gmbh | Sensorelement mit abgeschirmter Referenzelektrode |
| FR2911137B1 (fr) | 2007-01-05 | 2009-02-20 | Sanofi Aventis Sa | Nouveaux derives de 2,4-dianilinopyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk |
| US20100282245A1 (en) | 2007-01-12 | 2010-11-11 | Alexander Star | Detection of nitric oxide |
| JP2008180529A (ja) | 2007-01-23 | 2008-08-07 | Furukawa Electric Co Ltd:The | ガスセンサ |
| US20100185112A1 (en) * | 2007-06-27 | 2010-07-22 | Koninklijke Philips Electronics N.V. | Device for analysing an inflammatory status of a respiratory system |
| EP2280284A4 (en) | 2008-05-26 | 2014-10-29 | Panasonic Healthcare Co Ltd | Biosensor |
| US8366630B2 (en) | 2008-05-29 | 2013-02-05 | Technion Research And Development Foundation Ltd. | Carbon nanotube structures in sensor apparatuses for analyzing biomarkers in breath samples |
| JP2010025721A (ja) | 2008-07-18 | 2010-02-04 | Sharp Corp | ガスセンシング装置 |
| JP5420204B2 (ja) | 2008-07-18 | 2014-02-19 | 株式会社船井電機新応用技術研究所 | 携帯型の物質検出装置 |
| US9011670B2 (en) | 2008-08-14 | 2015-04-21 | The Charles Stark Draper Laboratory, Inc. | Three-dimensional metal ion sensor arrays on printed circuit boards |
| JP5422938B2 (ja) * | 2008-08-19 | 2014-02-19 | 凸版印刷株式会社 | 流体測定装置 |
| DE102008049768A1 (de) | 2008-09-30 | 2010-04-08 | Siemens Aktiengesellschaft | Nichtverbrauchendes Gas-Konversionsmodul |
| EP2361093A2 (en) | 2008-11-26 | 2011-08-31 | Five Prime Therapeutics, Inc. | Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| JP4903911B2 (ja) | 2009-03-16 | 2012-03-28 | シャープ株式会社 | 化学物質センシング装置およびそれを備える化学物質センシングシステム |
| DE102009016848B4 (de) * | 2009-04-08 | 2011-12-01 | Siemens Aktiengesellschaft | Gas-Analysegerät mit einer Kombination aus Gasentfeuchter und Gaskonverter |
| US8226825B2 (en) | 2009-04-09 | 2012-07-24 | The United States of America, as represented by the Sectretary of Commerce, The National Institute of Standards and Technology | Recirculating temperature wave focusing chromatography |
| CA2759104C (en) | 2009-04-24 | 2019-01-29 | Iceutica Pty Ltd | Method for improving the dissolution profile of a biologically active material |
| CN102438592B (zh) | 2009-04-24 | 2016-09-14 | 伊休蒂卡有限公司 | 甲氧萘普酸的剂型 |
| WO2010121324A1 (en) | 2009-04-24 | 2010-10-28 | Iceutica Pty Ltd | A novel formulation of metaxalone |
| GB2469803A (en) | 2009-04-27 | 2010-11-03 | Kanichi Rs Ltd | Electrochemical sensor |
| US8845660B2 (en) | 2009-08-06 | 2014-09-30 | Dsm Ip Assets B.V. | Surgical repair article based on HPPE material |
| DE102009029621A1 (de) | 2009-09-21 | 2011-03-24 | Robert Bosch Gmbh | Detektionsvorrichtung und Verfahren zur Detektion eines Gases |
| DE102009043222B4 (de) * | 2009-09-28 | 2018-10-18 | Robert Bosch Gmbh | Vorrichtung und Verfahren zur Messung mindestens eines Gasanalyten in Ausatemluft |
| CN102596030B (zh) * | 2009-11-03 | 2015-12-09 | 皇家飞利浦电子股份有限公司 | 用于测量呼出气中特定气体的水平的设备 |
| EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
| ITRM20110083U1 (it) | 2010-05-13 | 2011-11-14 | De La Cruz Jose Antonio Freire | Piastra per la costruzione di carrelli per aeroplani |
| EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
| US9536720B2 (en) | 2010-10-29 | 2017-01-03 | Atonarp Inc. | Analyzing apparatus |
| DE102011003291B4 (de) | 2011-01-28 | 2021-12-30 | Robert Bosch Gmbh | Betriebsverfahren für einen Gassensor und Gassensor |
| CN102253105B (zh) | 2011-06-15 | 2013-09-25 | 郑州炜盛电子科技有限公司 | 电化学传感器 |
| EP2725974A1 (en) | 2011-06-28 | 2014-05-07 | Fred Hutchinson Cancer Research Center | End-tidal gas monitoring apparatus |
| DE102011080765A1 (de) | 2011-07-08 | 2013-01-10 | Siemens Aktiengesellschaft | Überwachung der Funktionalität eines Konverters eines Atemanalysegerätes |
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| AU2013227351B2 (en) | 2012-02-28 | 2016-06-16 | Iceutica Holdings Inc. | Inhalable pharmaceutical compositions |
| JP5832479B2 (ja) | 2012-08-09 | 2015-12-16 | 日本特殊陶業株式会社 | ガスセンサ |
| EP2899538B1 (en) | 2012-09-19 | 2016-11-09 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor |
| EP2900132A4 (en) * | 2012-09-28 | 2016-07-06 | Univ Arizona | MOUTHPIECE FOR ACCURATE DETECTION OF EXTRACTED STAIN OXIDE |
| DE102012220598A1 (de) | 2012-11-13 | 2014-05-28 | BSH Bosch und Siemens Hausgeräte GmbH | Überwachungssystem und Verfahren zur Überwachung und Einstellung von Luftparametern in einem Raum, Dunstabzugsvorrichtung zur Verwendung in einem Überwachungssystem |
| EA201500651A1 (ru) | 2012-12-18 | 2015-11-30 | Альмираль, С.А. | НОВЫЕ ПРОИЗВОДНЫЕ ЦИКЛОГЕКСИЛ- И ХИНУКЛИДИНИЛКАРБАМАТА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3 |
| DE102013206111A1 (de) * | 2013-04-08 | 2014-10-09 | Robert Bosch Gmbh | Vorrichtung zur kombinierten Atemgasanalyse und Lungenfunktionsprüfung |
| DE102013221061A1 (de) | 2013-10-17 | 2015-04-23 | Robert Bosch Gmbh | Verfahren und Vorrichtung zur Messung der Konzentration von Stickstoffmonoxid in der Atemluft eines Patienten |
| DE102014210574A1 (de) | 2014-06-04 | 2015-12-17 | Robert Bosch Gmbh | Messvorrichtung und Verfahren zur Bestimmung der asthmatisch wirksamen Belastung bei einem Menschen oder Tier |
| WO2015191558A1 (en) * | 2014-06-09 | 2015-12-17 | Biometry Inc. | Low cost test strip and method to measure analyte |
| DE102014219132A1 (de) | 2014-09-23 | 2016-03-24 | Robert Bosch Gmbh | Vorrichtung zur Analyse der Ausatemluft mit einer Gassensoreinrichtung |
| DE102014219161A1 (de) | 2014-09-23 | 2016-03-24 | Robert Bosch Gmbh | Vorrichtung zur Analyse der Ausatemluft und Verwendung der Vorrichtung |
| DE102014219561A1 (de) | 2014-09-26 | 2016-03-31 | Robert Bosch Gmbh | Einrichtung zur Analyse von Substanzen in einer Probe, Atemgasanalysegerät, Kraftstoffsensor und Verfahren |
| ES3033732T3 (en) | 2014-12-24 | 2025-08-07 | Biometry Inc | Method to measure analytes with a gas chromatographic test strip |
| KR101786803B1 (ko) | 2016-05-24 | 2017-11-15 | 연세대학교 산학협력단 | Coffee-Ring Effect를 활용할 수 있는 가스 센서 플랫폼 및 그 제조방법 |
-
2017
- 2017-07-19 CA CA3031247A patent/CA3031247A1/en active Pending
- 2017-07-19 EP EP24204020.2A patent/EP4464772A3/en active Pending
- 2017-07-19 ES ES17831778T patent/ES2988367T3/es active Active
- 2017-07-19 CN CN202210510150.1A patent/CN114859028A/zh active Pending
- 2017-07-19 US US16/319,173 patent/US11255840B2/en active Active
- 2017-07-19 AU AU2017300528A patent/AU2017300528C1/en active Active
- 2017-07-19 JP JP2019502636A patent/JP7086927B2/ja active Active
- 2017-07-19 WO PCT/US2017/042830 patent/WO2018017699A1/en not_active Ceased
- 2017-07-19 CN CN201780056025.5A patent/CN109715067B/zh active Active
- 2017-07-19 EP EP17831778.0A patent/EP3487407B1/en active Active
-
2022
- 2022-01-13 US US17/575,090 patent/US12038428B2/en active Active
- 2022-06-08 JP JP2022092914A patent/JP7358563B2/ja active Active
-
2023
- 2023-09-27 JP JP2023164189A patent/JP7561941B2/ja active Active
-
2024
- 2024-06-04 US US18/733,764 patent/US20240402152A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN114859028A (zh) | 2022-08-05 |
| JP2023171847A (ja) | 2023-12-05 |
| US12038428B2 (en) | 2024-07-16 |
| EP3487407A4 (en) | 2019-11-13 |
| JP7561941B2 (ja) | 2024-10-04 |
| EP3487407A1 (en) | 2019-05-29 |
| US20240402152A1 (en) | 2024-12-05 |
| EP4464772A2 (en) | 2024-11-20 |
| US20220299499A1 (en) | 2022-09-22 |
| NZ750019A (en) | 2025-05-30 |
| EP3487407B1 (en) | 2024-10-02 |
| ES2988367T3 (es) | 2024-11-20 |
| JP7086927B2 (ja) | 2022-06-20 |
| CN109715067A (zh) | 2019-05-03 |
| AU2017300528A1 (en) | 2019-01-31 |
| EP3487407C0 (en) | 2024-10-02 |
| JP2022120051A (ja) | 2022-08-17 |
| WO2018017699A1 (en) | 2018-01-25 |
| JP2019526049A (ja) | 2019-09-12 |
| EP4464772A3 (en) | 2024-12-04 |
| AU2017300528B2 (en) | 2022-04-07 |
| AU2017300528C1 (en) | 2022-10-20 |
| US20200200733A1 (en) | 2020-06-25 |
| JP7358563B2 (ja) | 2023-10-10 |
| US11255840B2 (en) | 2022-02-22 |
| CN109715067B (zh) | 2022-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12038428B2 (en) | Methods of and systems for measuring analytes using batch calibratable test strips | |
| US11747324B2 (en) | Low cost test strip and method to measure analyte | |
| EP3237084B1 (en) | Method to measure analytes with a gas chromatographic test strip | |
| US20210239665A1 (en) | Mini point of care gas chromatographic test strip and method to measure analytes | |
| Macagnano et al. | Sensing asthma with portable devices equipped with ultrasensitive sensors based on electrospun nanomaterials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220718 |
|
| EEER | Examination request |
Effective date: 20220718 |
|
| EEER | Examination request |
Effective date: 20220718 |
|
| EEER | Examination request |
Effective date: 20220718 |
|
| EEER | Examination request |
Effective date: 20220718 |